PMID: 8589364Oct 1, 1995Paper

Early-onset respiratory syncytial virus pneumonia after allogeneic bone marrow transplantation

International Journal of Hematology
M TsuzukiM Hirano

Abstract

A 41-year-old woman with follicular lymphoma developed sporadic respiratory syncytial virus (RSV) pneumonia shortly after allogeneic bone marrow transplantation from an HLA-matched sibling. RSV pneumonia is potentially fatal in immunosuppressed patients, but she improved along with the recovery of bone marrow function without specific treatment. Early recovery of myelosuppression supported by granulocyte colony-stimulating factor may have helped to control RSV pneumonia.

Citations

Apr 22, 2004·AJR. American Journal of Roentgenology·Emerson L GasparettoNestor L Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.